罕见的组织学前列腺癌亚型:癌症特异性和其他原因死亡率
Carolin Siech1,2, Mario de Angelis3,4,5, Letizia Maria Ippolita Jannello3,6,7
1Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada. siech@med.uni-frankfurt.de.
Prostate cancer and prostatic diseases
|July 10, 2024
概括
患有神经内分泌癌等罕见前列腺癌亚型的患者面临更高的癌症特异性死亡率. 粘性和结环细胞亚型的死亡率与常见的状腺癌相似.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 流行病学 流行病学
背景情况:
- 前列腺癌表现出多种不同的组织学亚型,不仅仅是状腺癌.
- 罕见的亚型,包括管道,神经内分泌,粘膜和结环细胞癌,需要不同的预后评估.
- 了解癌症特异性死亡率 (CSM) 和其他原因死亡率 (OCM) 对这些罕见实体至关重要.
研究的目的:
- 在罕见的前列腺癌组织学亚型中比较癌症特异性死亡率 (CSM) 和其他原因死亡率 (OCM).
- 为了确定罕见的前列腺癌亚型和常见的状腺癌之间的预后差异.
主要方法:
- 从2004年到2020年使用了监测,流行病学和最终结果 (SEER) 数据库.
- 员工平滑累积发病率图表以可视化死亡率趋势.
- 应用竞争性风险回归 (CRR) 模型来分析CSM和OCM率.
主要成果:
- 与性腺癌相比,神经内分泌癌在所有阶段都显示出显著更高的CSM率.
- 局部发达的管道癌也显示了CSM相对于acinar腺癌的比率增加.
- 粘性和结环细胞癌的CSM发生率与性腺癌相比较.
结论:
- 神经内分泌和局部发达的导管性前列腺癌与较差的生存结果有关.
- 粘性和结环细胞前列腺癌似乎不会比性腺癌更糟糕的预后.
- 这些发现凸显了组织学亚型在预测前列腺癌患者结果方面的重要性.
相关概念视频
01:20Disorders of the Male Reproductive System
381
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
381
01:21Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340